• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠滋养细胞肿瘤:2014年最新进展

Gestational trophoblastic tumours: an update for 2014.

作者信息

Froeling Fieke E M, Seckl Michael J

机构信息

Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Imperial College Healthcare NHS Trust and Imperial College London, Fulham Palace Road, London, W6 8RF, UK.

出版信息

Curr Oncol Rep. 2014 Nov;16(11):408. doi: 10.1007/s11912-014-0408-y.

DOI:10.1007/s11912-014-0408-y
PMID:25318458
Abstract

Gestational trophoblastic disease describes a variety of pregnancy-related diseases including the premalignant conditions of a partial and complete hydatidiform mole and the malignant disorders of invasive mole, choriocarcinoma and the rare placental-site trophoblastic tumour and epithelioid trophoblastic tumour. The availability of a highly sensitive tumour marker in the form of human chorionic gonadotrophin, the chemosensitive character of the disease with effective treatment strategies and centralization of care of a rare group of diseases has resulted in excellent survival rates, which can exceed 98 %. This review gives a general overview of gestational trophoblastic disease, the most recent insights in aetiology and pathology and a summary of the different management strategies.

摘要

妊娠滋养细胞疾病描述了多种与妊娠相关的疾病,包括部分性和完全性葡萄胎的癌前病变以及侵蚀性葡萄胎、绒毛膜癌、罕见的胎盘部位滋养细胞肿瘤和上皮样滋养细胞肿瘤等恶性疾病。以人绒毛膜促性腺激素形式存在的高敏感性肿瘤标志物、有效治疗策略下疾病的化疗敏感性以及对这一罕见疾病群体的集中护理,使得生存率极高,可超过98%。本综述对妊娠滋养细胞疾病、病因学和病理学的最新见解以及不同管理策略进行了概述。

相似文献

1
Gestational trophoblastic tumours: an update for 2014.妊娠滋养细胞肿瘤:2014年最新进展
Curr Oncol Rep. 2014 Nov;16(11):408. doi: 10.1007/s11912-014-0408-y.
2
Gestational trophoblastic disease.妊娠滋养细胞疾病。
Lancet. 2010 Aug 28;376(9742):717-29. doi: 10.1016/S0140-6736(10)60280-2. Epub 2010 Jul 29.
3
Clinical presentation and diagnosis of Gestational Trophoblastic Disease.妊娠滋养细胞疾病的临床表现与诊断。
Best Pract Res Clin Obstet Gynaecol. 2021 Jul;74:42-52. doi: 10.1016/j.bpobgyn.2020.12.001. Epub 2020 Dec 21.
4
Advances in diagnostics and management of gestational trophoblastic disease.妊娠滋养细胞疾病的诊断和治疗进展。
Radiol Oncol. 2022 Oct 27;56(4):430-439. doi: 10.2478/raon-2022-0038. eCollection 2022 Dec 1.
5
[Gestational trophoblastic disease].[妊娠滋养细胞疾病]
Ann Pathol. 2014 Dec;34(6):434-47. doi: 10.1016/j.annpat.2014.09.004. Epub 2014 Nov 14.
6
Gestational trophoblastic disease- rare, sometimes dramatic, and what we know so far.妊娠滋养细胞疾病——罕见,有时病情严重,以及我们目前所了解的情况。
Semin Diagn Pathol. 2022 May;39(3):228-237. doi: 10.1053/j.semdp.2022.03.002. Epub 2022 Mar 22.
7
Guideline No. 408: Management of Gestational Trophoblastic Diseases.指南 408:妊娠滋养细胞疾病的管理。
J Obstet Gynaecol Can. 2021 Jan;43(1):91-105.e1. doi: 10.1016/j.jogc.2020.03.001.
8
Pathology of gestational trophoblastic diseases.妊娠滋养细胞疾病的病理学
Best Pract Res Clin Obstet Gynaecol. 2003 Dec;17(6):849-68. doi: 10.1016/s1521-6934(03)00094-4.
9
[GESTATIONAL TROPHOBLASTIC DISEASE: THE NEED FOR CENTRALIZATION OF TREATMENT CENTERS IN ISRAEL].[妊娠滋养细胞疾病:以色列治疗中心集中化的必要性]
Harefuah. 2022 Aug;161(8):494-499.
10
Pathology of gestational trophoblastic disease (GTD).妊娠滋养细胞疾病(GTD)的病理学。
Best Pract Res Clin Obstet Gynaecol. 2021 Jul;74:3-28. doi: 10.1016/j.bpobgyn.2021.02.005. Epub 2021 Mar 31.

引用本文的文献

1
Gestational trophoblastic diseases - literature review and atypical case reports.妊娠滋养细胞疾病——文献综述与非典型病例报告
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):7-30. doi: 10.47162/RJME.66.1.01.
2
Epigenetic regulation in female reproduction: the impact of m6A on maternal-fetal health.女性生殖中的表观遗传调控:m6A对母婴健康的影响。
Cell Death Discov. 2025 Feb 4;11(1):43. doi: 10.1038/s41420-025-02324-z.
3
Epithelioid trophoblastic tumor with lung metastasis: A case report and literature review.上皮样滋养细胞肿瘤伴肺转移:病例报告并文献复习。

本文引用的文献

1
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.单药化疗与联合化疗治疗妊娠滋养细胞肿瘤对继发恶性肿瘤和早绝经风险的影响。
J Clin Oncol. 2015 Feb 10;33(5):472-8. doi: 10.1200/JCO.2014.57.5332. Epub 2014 Dec 29.
2
Effect of early pregnancy following chemotherapy on disease relapse and fetal outcome in women treated for gestational trophoblastic neoplasia.化疗后早期妊娠对妊娠滋养细胞肿瘤治疗后女性疾病复发及胎儿结局的影响。
J Reprod Med. 2014 May-Jun;59(5-6):248-54.
3
Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease.
Medicine (Baltimore). 2024 Jul 5;103(27):e38108. doi: 10.1097/MD.0000000000038108.
4
In Vivo Quantitative Assessment of Gestational Choriocarcinoma Development and Progression Using Luminescent Trophoblast Cells.利用发光滋养层细胞对妊娠绒癌的发生发展进行体内定量评估。
Methods Mol Biol. 2024;2728:77-85. doi: 10.1007/978-1-0716-3495-0_6.
5
Gestational trophoblastic neoplasia of intermediate trophoblasts: Epithelioid trophoblastic tumor and placental site trophoblastic tumor, a study of morphologic, immunohistochemical, and next generation sequencing.中间型滋养细胞性妊娠滋养细胞肿瘤:上皮样滋养细胞肿瘤和胎盘部位滋养细胞肿瘤,一项关于形态学、免疫组织化学及二代测序的研究
Turk J Obstet Gynecol. 2023 Jun 1;20(2):105-112. doi: 10.4274/tjod.galenos.2023.73549.
6
The role of insulin-like growth factor 2 mRNA binding proteins in female reproductive pathophysiology.胰岛素样生长因子 2 mRNA 结合蛋白在女性生殖病理生理学中的作用。
Reprod Biol Endocrinol. 2022 Jun 15;20(1):89. doi: 10.1186/s12958-022-00960-z.
7
ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma.ATR 和 CDK4/6 抑制作用靶向甲氨蝶呤耐药绒癌的生长。
Oncogene. 2022 Apr;41(18):2540-2554. doi: 10.1038/s41388-022-02251-8. Epub 2022 Mar 18.
8
MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN.葡萄胎中 miRNA 表达谱分析用于预测绒癌后 GTN:绒癌后 GTN 的 miRNA 谱。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338211067309. doi: 10.1177/15330338211067309.
9
miR-497-5p/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation.miR-497-5p/SALL4 轴促进绒毛膜癌的干性表型,并与 DNMT 介导的表观遗传调控形成反馈回路。
Cell Death Dis. 2021 Nov 3;12(11):1046. doi: 10.1038/s41419-021-04315-1.
10
NLRP7 Promotes Choriocarcinoma Growth and Progression through the Establishment of an Immunosuppressive Microenvironment.NLRP7通过建立免疫抑制微环境促进绒毛膜癌的生长和进展。
Cancers (Basel). 2021 Jun 15;13(12):2999. doi: 10.3390/cancers13122999.
早期葡萄胎的组织病理学和免疫组化特征与持续性妊娠滋养细胞疾病后续发展的关系
J Reprod Med. 2014 May-Jun;59(5-6):213-20.
4
Worldwide survey of the results of treating gestational trophoblastic disease.全球妊娠滋养细胞疾病治疗结果调查。
J Reprod Med. 2014 Mar-Apr;59(3-4):145-53.
5
Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010.FIGO高危妊娠滋养细胞肿瘤患者的管理与生存情况:英国1995 - 2010年的经验
J Reprod Med. 2014 Jan-Feb;59(1-2):7-12.
6
Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.妊娠滋养细胞疾病:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi39-50. doi: 10.1093/annonc/mdt345. Epub 2013 Sep 1.
7
Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.联合化疗用于高危妊娠滋养细胞肿瘤的初始治疗
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD005196. doi: 10.1002/14651858.CD005196.pub4.
8
EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.EMA/CO 方案治疗高危妊娠滋养细胞肿瘤:低剂量依托泊苷-顺铂诱导化疗联合遗传分析的良好疗效。
J Clin Oncol. 2013 Jan 10;31(2):280-6. doi: 10.1200/JCO.2012.43.1817. Epub 2012 Dec 10.
9
Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009.2000-2009 年查令十字医院 618 例葡萄胎妊娠后滋养细胞肿瘤患者的治疗结果。
Br J Cancer. 2012 Nov 20;107(11):1810-4. doi: 10.1038/bjc.2012.462. Epub 2012 Oct 11.
10
Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.放线菌素D用于甲氨蝶呤治疗失败的低危妊娠滋养细胞肿瘤。
J Reprod Med. 2012 Jul-Aug;57(7-8):283-7.